HighTower Advisors
ACHV icon

HighTower Advisors’s Achieve Life Sciences ACHV Stock Holding History

HighTower Advisors’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-12
Closed -$27K – 1869
2016
Q2 		$27K Sell
12
-1
-8% -$2.09K ﹤0.01% 1668
2016
Q1 		$18K Sell
13
-6
-32% -$9.78K ﹤0.01% 2020
2015
Q4 		$48K Buy
19
+2
+12% +$8.45K ﹤0.01% 1897
2015
Q3 		$83K Buy
+17
New +$102K ﹤0.01% 1743

Other funds holding ACHV

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $2.78B AUM 26.09% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HighTower Advisors's ACHV Position: Q3 2016 in Review

HighTower Advisors sold out of Achieve Life Sciences (ACHV) in Q3 2016, closing a stake of 12 shares — an estimated $27K sold.

HighTower Advisors first reported a position in ACHV in Q3 2015 and held it in 4 quarters. The position peaked at $83K in Q3 2015. 29 funds tracked by Wall St. Rank hold ACHV as of Q3 2016.

  • HighTower Advisors reported no remaining Achieve Life Sciences position as of Q3 2016 after selling out during the quarter.
  • HighTower Advisors sold 12 Achieve Life Sciences shares in Q3 2016, an estimated $27K.
  • HighTower Advisors first reported a position in Achieve Life Sciences in Q3 2015 and held it in 4 quarters.
  • HighTower Advisors's Achieve Life Sciences position peaked at $83K in Q3 2015.
  • 29 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2016.

Based on HighTower Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.